Delivery Order SPE2DB22D1106-SPE2DB24FFHB2
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a ceiling value of $23,488.81 and a completion date of February 8, 2023. It is a firm-fixed-price contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,477.90 and an ultimate completion date of November 13, 2024. It is a firm-fixed-price contract for the delivery of Activase 100 mg vials, a medication used for the treatment of acute ischemic stroke. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 100 mg vials of Activase, a medication used for the treatment of certain medical conditions. The contract has a ceiling value of $8,338.46 and a period of performance through January 14, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 50 mg vials of Activase, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $10,002.01 and a period of performance through May 28, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a firm fixed price and a ceiling value of $19,874.43. There is no set-aside designation for this award. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various agencies, including the DLA Troop Support Medical and the Department of Justice...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Activase 50 mg vials, a medication used to treat acute ischemic stroke. The contract has a ceiling value of $25,180.43 and a period of performance through May 12, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,567,132,141 units of the drug Activase 50 mg vials. The fixed-price contract has a ceiling value of $5,935.94 and a period of performance through February 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 50 mg vials of the pharmaceutical product Activase, with a ceiling value of $2,915.07 and a period of performance through March 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a firm fixed price of $17,103.37 and a completion date of September 6, 2024. Amerisourcebergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,743.76 and is for the delivery of ACTIVASE 50 MG VIALS, a medical product. It is a firm fixed price contract with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...